Stagwell (STGW): Is This Single-Digit Stock a Hidden Health Gem or a Value Trap?
Stagwell (STGW) reported Q2 revenue of $786M, up 11% YoY, with adjusted EBITDA at $109M. The company launched a healthcare division, Allison Worldwide Health Group, targeting growth sectors. Despite revenue growth, GAAP net loss widened to $8M. Hedge fund holdings declined, and short interest is high. STGW trades at 5.87x forward earnings. Investors watch for operational execution to align with raised guidance.



